Registration of peer reviews for journal articles is supported as of schema version 4.4.1. Peer reviews include referee reports, decision letters, and author responses. Members may also register post-publication reviews using our peer review content type.
Peer review metadata includes a number of review-specific elements. Many are optional to accommodate variances in review practices but please include all elements relevant to your reviews when submitting your metadata records.
Note that all reviews must include relations metadata linking the review with the journal article being reviewed.
| Elements | Description | Limits |
|---|---|---|
|
contributor, includes |
Captures reviewer name and role. If anonymous must capture as <anonymous/>. Peer review roles are:
|
optional |
| title | Title of review. If you don’t have a review-specific title convention, we recommend that you include ‘Review (or publishers’ own term for ‘review’) in your peer review registration, as well as a revision and review number. For example, a review pattern of Review: title of article (Revision number/Review number) will be: "Review: Analysis of the effects of bad metadata on discoverability (R2/RC3)" |
required |
| review_date | Date of review, incl. month, day, year | year required |
| institution | Organization (publisher or other) submitting the peer review, strongly advised if submitter differs from publisher of item being reviewed | optional, may incl. up to 5 |
| competing_interest_statement | Competing interest statement provided by review author during review process | optional |
| running_number | Internal number/identifier used to identify specific review | optional |
| License data | Text or data mining license info | optional |
| Relations | Relate review to item being reviewed through relations - must supply the DOI of item being reviewed as an inter-work relation with review type “isReviewOf” | required |
Some metadata is captured as attributes with specific enumerated values.
| Attributes | Description | Limits |
|---|---|---|
| stage | options are “pre-publication” and “post-publication" | optional |
| type | Types of report include:
|
optional |
| recommendation | Values are:
|
optional |
| revision-round | Revision round number, first submission is defined as revision round 0 | optional |
| language | Language of review | optional |
Examples
Connecting a review to the reviewed item through relations
<program xmlns="http://www.crossref.org/relations.xsd">
<related_item>
<description>Referee report of Treatment of plaque psoriasis with an ointment
formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized
clinical trial</description>
<inter_work_relation relationship-type="isReviewOf" identifier-type="doi"
>10.1186/s12895-016-0051-4</inter_work_relation>
</related_item>
</program>
A complete review
<?xml version="1.0" encoding="UTF-8"?>
<doi_batch xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.crossref.org/schema/4.4.2 http://www.crossref.org/schema/crossref4.4.2.xsd"
xmlns="http://www.crossref.org/schema/4.4.2" version="4.4.2">
<head>
<doi_batch_id>20170807</doi_batch_id>
<timestamp>2017080715731</timestamp>
<depositor>
<depositor_name>Crossref</depositor_name>
<email_address>support@crossref.org</email_address>
</depositor>
<registrant>Crossref</registrant>
</head>
<body>
<peer_review stage="pre-publication" revision-round="1" recommendation="accept">
<contributors>
<person_name contributor_role="reviewer" sequence="first">
<given_name>Wilson</given_name>
<surname>Liao</surname>
</person_name>
</contributors>
<titles>
<title>Review: Treatment of plaque psoriasis with an ointment formulation of the Januskinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial. V1</title>
</titles>
<review_date>
<month>08</month>
<day>19</day>
<year>2016</year>
</review_date>
<competing_interest_statement> There were no competing interests</competing_interest_statement>
<running_number>RC1 </running_number>
<program xmlns="http://www.crossref.org/relations.xsd">
<related_item>
<description>Referee report of Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial</description>
<inter_work_relation relationship-type="isReviewOf" identifier-type="doi"
>10.1186/s12895-016-0051-4 </inter_work_relation>
</related_item>
</program>
<doi_data>
<doi>10.5555/abc123</doi>
<resource>https://www.example.org/openpeerreview/art%3A10.1186%2Fs12895-016-0051-4/12895_2016_51_ReviewerReport_V2_R1.pdf</resource>
</doi_data>
</peer_review>
</body>
</doi_batch>
Comments
0 comments
Please sign in to leave a comment.